60 Degrees Pharmaceuticals (SXTP) Competitors $1.44 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$1.44 +0.01 (+0.35%) As of 06:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock SXTP vs. FBLG, PASG, LIXT, PMN, TAOX, QTTB, PRPH, ASBP, SONN, and SNYRShould you be buying 60 Degrees Pharmaceuticals stock or one of its competitors? The main competitors of 60 Degrees Pharmaceuticals include FibroBiologics (FBLG), Passage Bio (PASG), Lixte Biotechnology (LIXT), Promis Neurosciences (PMN), Synaptogenix (TAOX), Q32 Bio (QTTB), ProPhase Labs (PRPH), Aspire Biopharma (ASBP), Sonnet BioTherapeutics (SONN), and Synergy CHC (SNYR). These companies are all part of the "pharmaceutical products" industry. 60 Degrees Pharmaceuticals vs. Its Competitors FibroBiologics Passage Bio Lixte Biotechnology Promis Neurosciences Synaptogenix Q32 Bio ProPhase Labs Aspire Biopharma Sonnet BioTherapeutics Synergy CHC 60 Degrees Pharmaceuticals (NASDAQ:SXTP) and FibroBiologics (NASDAQ:FBLG) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations. Which has more volatility and risk, SXTP or FBLG? 60 Degrees Pharmaceuticals has a beta of 2.73, meaning that its stock price is 173% more volatile than the S&P 500. Comparatively, FibroBiologics has a beta of -0.73, meaning that its stock price is 173% less volatile than the S&P 500. Does the media prefer SXTP or FBLG? In the previous week, FibroBiologics had 5 more articles in the media than 60 Degrees Pharmaceuticals. MarketBeat recorded 7 mentions for FibroBiologics and 2 mentions for 60 Degrees Pharmaceuticals. 60 Degrees Pharmaceuticals' average media sentiment score of 0.64 beat FibroBiologics' score of 0.05 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 60 Degrees Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive FibroBiologics 0 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better valuation & earnings, SXTP or FBLG? 60 Degrees Pharmaceuticals has higher revenue and earnings than FibroBiologics. FibroBiologics is trading at a lower price-to-earnings ratio than 60 Degrees Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio60 Degrees Pharmaceuticals$300K19.68-$7.95M-$50.41-0.03FibroBiologicsN/AN/A-$11.16M-$0.36-1.46 Do analysts prefer SXTP or FBLG? 60 Degrees Pharmaceuticals presently has a consensus target price of $3.00, indicating a potential upside of 108.33%. FibroBiologics has a consensus target price of $12.50, indicating a potential upside of 2,279.14%. Given FibroBiologics' stronger consensus rating and higher probable upside, analysts clearly believe FibroBiologics is more favorable than 60 Degrees Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 60 Degrees Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50FibroBiologics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is SXTP or FBLG more profitable? FibroBiologics has a net margin of 0.00% compared to 60 Degrees Pharmaceuticals' net margin of -976.86%. 60 Degrees Pharmaceuticals' return on equity of 0.00% beat FibroBiologics' return on equity.Company Net Margins Return on Equity Return on Assets 60 Degrees Pharmaceuticals-976.86% N/A -133.88% FibroBiologics N/A -710.25%-118.02% Do insiders and institutionals have more ownership in SXTP or FBLG? 8.0% of 60 Degrees Pharmaceuticals shares are owned by institutional investors. 1.7% of 60 Degrees Pharmaceuticals shares are owned by company insiders. Comparatively, 20.0% of FibroBiologics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryFibroBiologics beats 60 Degrees Pharmaceuticals on 8 of the 15 factors compared between the two stocks. Get 60 Degrees Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SXTP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SXTP vs. The Competition Export to ExcelMetric60 Degrees PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.90M$2.53B$5.73B$10.28BDividend YieldN/A56.56%5.88%4.63%P/E Ratio-0.0323.2976.7426.53Price / Sales19.68667.50526.07121.12Price / CashN/A169.4937.2060.52Price / Book-0.235.2913.946.31Net Income-$7.95M$32.95M$3.29B$271.37M7 Day Performance0.70%0.85%0.63%2.11%1 Month Performance9.09%3.80%4.32%6.67%1 Year Performance-80.00%-3.99%84.13%27.84% 60 Degrees Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SXTP60 Degrees Pharmaceuticals2.0089 of 5 stars$1.44flat$3.00+108.3%-79.3%$5.90M$300K-0.033News CoverageFBLGFibroBiologics3.4334 of 5 stars$0.54-5.5%$13.00+2,315.0%-83.7%$22.55MN/A-1.5010PASGPassage Bio4.0998 of 5 stars$7.00+1.2%$75.67+981.0%-50.2%$22.26MN/A-0.39130News CoveragePositive NewsInsider TradeGap DownLIXTLixte Biotechnology0.8568 of 5 stars$4.80+11.1%N/A+176.0%$21.89MN/A-3.724News CoverageGap UpPMNPromis Neurosciences3.669 of 5 stars$0.42-3.7%$4.33+929.3%-69.3%$21.81MN/A-2.005Positive NewsShort Interest ↓TAOXSynaptogenix0.1602 of 5 stars$6.24-0.5%N/AN/A$21.78MN/A-0.314QTTBQ32 Bio2.7685 of 5 stars$1.78+1.7%$12.17+583.5%-95.8%$21.72M$1.16M-0.4139PRPHProPhase Labs1.1857 of 5 stars$0.52+35.5%N/A-81.9%$21.39M$5.59M-0.41130High Trading VolumeASBPAspire BiopharmaN/A$0.43-15.9%N/AN/A$21.32MN/A0.00N/ANews CoverageSONNSonnet BioTherapeutics2.8901 of 5 stars$3.12-5.2%$20.00+541.0%-6.8%$21.31M$20K0.0010Positive NewsGap UpSNYRSynergy CHC3.9781 of 5 stars$2.24-2.2%$10.00+346.4%N/A$21.15M$33.70M5.8940Gap Down Related Companies and Tools Related Companies FBLG Competitors PASG Competitors LIXT Competitors PMN Competitors TAOX Competitors QTTB Competitors PRPH Competitors ASBP Competitors SONN Competitors SNYR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SXTP) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 60 Degrees Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 60 Degrees Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SXTP Stock Alerts